bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Data from Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
Authors: Li Chunlin , Zhang Nengpan , Zhou Jundong , Ding Chen , Jin Yaqing , Cui Xueyuan , Pu Kefeng , Zhu Yimin
Published: April 2023

Fig. S1. The binding specificity of consensus sequence CWCWR to MDA-MB-435 and MDA-MB-231 cells. Fig. S2. A, The schematic illustration of construction the focused library. B, Ten clones were randomly selected for sequencing to examine the diversity of the focused library. Fig. S3. Binding properties of peptides displayed on the bacteria surface. Fig. S4. The binding properties of TPP-1 and SPP-1 to PD-L1 were determined by the ELISA (n=3). Fig. S5. A, The PD-L1 expression of CHO-K1/PD-L1, MDA-MB-231 and MDA-MB-435 cell lines were determined by anti-PD-L1 antibody and flow cytometer. B, The binding properties of TPP-1 to MDA-MB-231 and MDA-MB-435 cell lines. Fig. S6. The bright field (A) and fluorescence microscopic image (B) of TPP-1 to CHO-K1. The bright field (C) and fluorescence microscopic image (D) of TPP-1 to CHO-K1/PD-L1. Fig. S7. A, The ED50 of PD-L1 to block the activated T cells (n=3). B, The TPP-1 peptide or PD-L1 plus TPP-1 peptide did not activate the T cells without the CD3 antibody. C, TPP-1 could effectively restore T cells proliferation which were inhibited by PD-L1 evaluated by T cell activation assay (n=3). Data were presented as mean {plus minus} SEM, *P<0.05, **P<0.01, unpaired t-test. Fig. S9. A, The bioluminescence signals of H460-Luc cells were determined by Cytation 3. B, The expression of PD-L1 on H460 was detected with flow cytometry. Fig. S8. A, The PD-L1 expression in matured DCs, the dotted line represented the isotype mAb and filled line represented the anti-PD-L1 mAb. B, The proliferation of T cells in MLR assay (n=3). Fig. S9. A, The bioluminescence signals of H460-Luc cells were determined by Cytation 3. B, The expression of PD-L1 on H460 was detected with flow cytometry. Fig. S10. A, In vivo fluorescence images of mice taken at different time points post s.c. injection of FITC labeled TPP-1. B, The statistical result of the relative fluorescence unit. Fig. S11. A, The location of CWCWR (yellow) in TPP-1 peptide. B, The possible binding location of TPP-1 (blue) peptide to PD-L1 (PDB ID of PD-L1: 3BIS). C, The crystal structures of PD-1 (light sea green) and PD-L1 (dark khaki) complex (PDB ID of the complex: 3BIK).
Figure S2 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells
Authors: Beavis Paul A. , Henderson Melissa A. , Giuffrida Lauren , Davenport Alexander J. , Petley Emma V. , House Imran G. , Lai Junyun , Sek Kevin , Milenkovski Nicole , John Liza B. , Mardiana Sherly , Slaney Clare Y. , Trapani Joseph A. , Loi Sherene , Kershaw Michael H. , Haynes Nicole M. , Darcy Phillip K.
Published: April 2023

Supplementary Figure 2
Supplementary methods, tables, figures S1-S7 from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment
Authors: Nath Pulak Ranjan , Pal-Nath Dipasmita , Mandal Ajeet , Cam Margaret C. , Schwartz Anthony L. , Roberts David D.
Published: April 2023

Tables S1, S2 Figures S1-S7
Supplementary Data from Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages
Authors: Zha Haoran , Wang Xinxin , Zhu Ying , Chen Diangang , Han Xiao , Yang Fei , Gao Jianbao , Hu Chunyan , Shu Chi , Feng Yi , Tan Yulong , Zhang Jinyu , Li Yongsheng , Wan Yisong Y. , Guo Bo , Zhu Bo
Published: April 2023

6 figures and 1 table are included
Supplementary Tables. Gene Lists Used in Signature Derivation and Analysis from Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients
Authors: Ly Dalam , Zhu Chang-Qi , Cabanero Michael , Tsao Ming-Sound , Zhang Li
Published: April 2023

Supplementary Table S2. Immune-related probesets used in signature development. The list of probesets from NIAID ImmPort Comprehensive List of Immune-Related Genes (version 2011_08_01) mapped onto Affymetrix U133 Plus 2 array by querying Netaffy (https://www.affymetrix.com/analysis/netaffx/) using gene symbol. Supplementary Table S3. 191 probe-set significantly associated with 5-year survival. Probeset and mapped gene symbol showed with univariate hazard ratio. Supplementary Table S4. Mast cell and basophil specific genes. Murine mast cell and basophil specific genes mapped to human Affymetrix U133 Plus 2 microarray used in spearman correlation analysis to 9-gene signature.
Supplementary Table S9 from Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients
Authors: Ly Dalam , Zhu Chang-Qi , Cabanero Michael , Tsao Ming-Sound , Zhang Li
Published: April 2023

MS4A2 expression and associations to clinicopathologic markers
Supplementary Table S8 from Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients
Authors: Ly Dalam , Zhu Chang-Qi , Cabanero Michael , Tsao Ming-Sound , Zhang Li
Published: April 2023

9-gene signature validation in individual datasets for overall survival and disease free survival of lung adenocarcinoma. Nine independent datasets where overall survival data were available were used to validate whether the 9-gene signature is able to classify patients into high or low risk for 5-year overall survival. Hazard ratio with 95%CI displayed with p value indicating significance.
Supplementary Data 2 from The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity
Authors: Danilova Ludmila , Anagnostou Valsamo , Caushi Justina X. , Sidhom John-William , Guo Haidan , Chan Hok Yee , Suri Prerna , Tam Ada , Zhang Jiajia , Asmar Margueritta El , Marrone Kristen A. , Naidoo Jarushka , Brahmer Julie R. , Forde Patrick M. , Baras Alexander S. , Cope Leslie , Velculescu Victor E. , Pardoll Drew M. , Housseau Franck , Smith Kellie N.
Published: April 2023

This is the FEST analysis output file for patient JH124
Supplementary Table S7 from Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients
Authors: Ly Dalam , Zhu Chang-Qi , Cabanero Michael , Tsao Ming-Sound , Zhang Li
Published: April 2023

9-gene signature and prognostic significance in lung cancer subtypes amongst validation dataset
Supplementary Data 1 from The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity
Authors: Danilova Ludmila , Anagnostou Valsamo , Caushi Justina X. , Sidhom John-William , Guo Haidan , Chan Hok Yee , Suri Prerna , Tam Ada , Zhang Jiajia , Asmar Margueritta El , Marrone Kristen A. , Naidoo Jarushka , Brahmer Julie R. , Forde Patrick M. , Baras Alexander S. , Cope Leslie , Velculescu Victor E. , Pardoll Drew M. , Housseau Franck , Smith Kellie N.
Published: April 2023

This is the FEST analysis output file for donor JH014
Supplementary Table S6 from Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients
Authors: Ly Dalam , Zhu Chang-Qi , Cabanero Michael , Tsao Ming-Sound , Zhang Li
Published: April 2023

Multivariate analysis showing effect of prognostic factors on 9-gene signature in training dataset.
Supplementary Table S1 from Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients
Authors: Ly Dalam , Zhu Chang-Qi , Cabanero Michael , Tsao Ming-Sound , Zhang Li
Published: April 2023

NSCLC validation dataset demographics. Patient numbers shown with demographic information. *exclude BR10 cases and cases with adjuvant chemotherapy, ** 1 case without stage information, ***14 cases without stage information and 1 case without follow-up.
Supplementary Figure Legends from Role for High-Affinity IgE Receptor in Prognosis of Lung Adenocarcinoma Patients
Authors: Ly Dalam , Zhu Chang-Qi , Cabanero Michael , Tsao Ming-Sound , Zhang Li
Published: April 2023

Supplementary Figure and Table Legends
Supplementary Figure 7 from NK Cell Education in Tumor Immune Surveillance: DNAM-1/KIR Receptor Ratios as Predictive Biomarkers for Solid Tumor Outcome
Authors: Guillamón Concepción F. , Martínez-Sánchez María V. , Gimeno Lourdes , Mrowiec Anna , Martínez-García Jerónimo , Server-Pastor Gerardo , Martínez-Escribano Jorge , Torroba Amparo , Ferri Belén , Abellán Daniel , Campillo José A. , Legaz Isabel , López-Álvarez María R. , Moya-Quiles María Rosa , Muro Manuel , Minguela Alfredo
Published: April 2023

Supplementary Figure 7
Figure S2 from Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist
Authors: Polesso Fanny , Weinberg Andrew D. , Moran Amy E.
Published: April 2023

Figure S2 shows that tumor bearing animals that cleared their primary tumor are projected from tumor rechallenge.
Supplementary Figures S1-S8 from USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity
Authors: Huang Xing , Zhang Qi , Lou Yu , Wang Junli , Zhao Xinyu , Wang Lin , Zhang Xiaozhen , Li Shanshan , Zhao Yulan , Chen Qi , Liang Tingbo , Bai Xueli
Published: April 2023

This file contains supplemental figures S1-S8, and the detailed description is as follows: Figure S1 shows USP22 binding to HLEET motif of CD274. Figure S2 shows USP22 stabilizing CD274 in CDK4-independent manner. Figure S3 shows the non-requirement of CD274 for USP22-controlled cancer cell growth in vitro. Figure S4 shows the expression profile of USP22 in multiple cancers. Figure S5 shows the CD274-independent roles of USP22 in liver cancer growth and therapy. Figure S6 shows the expression levels of CD274 in USP22-regulated tumor immunity. Figure S7 shows the negative correlation of USP22 and immune signatures in LIHC. Figure S8 shows the schematic model.
Supplementary Table 1 from Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells
Authors: Sun Bin , Yang Dong , Dai Hongjiu , Liu Xiuyun , Jia Ru , Cui Xiaoyue , Li Wenxuan , Cai Changchun , Xu Jianming , Zhao Xudong
Published: April 2023

The amino acid sequence of NKG2D-BBz and CD19-BBz
Supplementary Legends from Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer
Authors: Ye Jian , Mills Bradley N. , Zhao Tony , Han Booyeon J. , Murphy Joseph D. , Patel Ankit P. , Johnston Carl J. , Lord Edith M. , Belt Brian A. , Linehan David C. , Gerber Scott A.
Published: April 2023

Supplemental figure legends and supplemental tables
Figure S3 from Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer
Authors: Ye Jian , Mills Bradley N. , Zhao Tony , Han Booyeon J. , Murphy Joseph D. , Patel Ankit P. , Johnston Carl J. , Lord Edith M. , Belt Brian A. , Linehan David C. , Gerber Scott A.
Published: April 2023

Supplemental figure 3
Figure S2 from Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic Cancer
Authors: Ye Jian , Mills Bradley N. , Zhao Tony , Han Booyeon J. , Murphy Joseph D. , Patel Ankit P. , Johnston Carl J. , Lord Edith M. , Belt Brian A. , Linehan David C. , Gerber Scott A.
Published: April 2023

Supplemental figure 2
Supplementary File S1 from Mouse PVRIG Has CD8+ T Cell–Specific Coinhibitory Functions and Dampens Antitumor Immunity
Authors: Murter Benjamin , Pan Xiaoyu , Ophir Eran , Alteber Zoya , Azulay Meir , Sen Rupashree , Levy Ofer , Dassa Liat , Vaknin Ilan , Fridman-Kfir Tal , Salomon Ran , Ravet Achinoam , Tam Ada , Levin Doron , Vaknin Yakir , Tatirovsky Evgeny , Machlenkin Arthur , Pardoll Drew , Ganguly Sudipto
Published: April 2023

List of 145 differentially-expressed genes in PVRIG-knockout vs wild-type CD8 TILs (day 18 post-implantation).
Supplementary Figure legends from The E3 Ubiquitin Ligase Asb2α in T Helper 2 Cells Negatively Regulates Antitumor Immunity in Colorectal Cancer
Authors: Spinner Camille A. , Lamsoul Isabelle , Métais Arnaud , Febrissy Chanaëlle , Moog-Lutz Christel , Lutz Pierre G.
Published: April 2023

Supplementary Figure legends
Table S5 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
Authors: Bouwstra Renée , He Yuan , de Boer Janneke , Kooistra Hilde , Cendrowicz Ewa , Fehrmann Rudolf S.N. , Ammatuna Emanuele , zu Eulenburg Christine , Nijland Marcel , Huls Gerwin , Bremer Edwin , van Meerten Tom
Published: April 2023

Univariate analysis in R-CHOP treated non-GCB patients
Table S2 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
Authors: Bouwstra Renée , He Yuan , de Boer Janneke , Kooistra Hilde , Cendrowicz Ewa , Fehrmann Rudolf S.N. , Ammatuna Emanuele , zu Eulenburg Christine , Nijland Marcel , Huls Gerwin , Bremer Edwin , van Meerten Tom
Published: April 2023

Patient characteristics
Table S1 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL
Authors: Bouwstra Renée , He Yuan , de Boer Janneke , Kooistra Hilde , Cendrowicz Ewa , Fehrmann Rudolf S.N. , Ammatuna Emanuele , zu Eulenburg Christine , Nijland Marcel , Huls Gerwin , Bremer Edwin , van Meerten Tom
Published: April 2023

GEO accession numbers
Supplementary Figure 4 from The Gut Microbiome Associates with Immune Checkpoint Inhibition Outcomes in Patients with Advanced Non–Small Cell Lung Cancer
Authors: Hakozaki Taiki , Richard Corentin , Elkrief Arielle , Hosomi Yukio , Benlaïfaoui Myriam , Mimpen Iris , Terrisse Safae , Derosa Lisa , Zitvogel Laurence , Routy Bertrand , Okuma Yusuke
Published: April 2023

Supplementary Figure 4
Supplementary Figures from Myeloid-Derived Suppressive Cells Promote B cell–Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma
Authors: Lee-Chang Catalina , Rashidi Aida , Miska Jason , Zhang Peng , Pituch Katarzyna C. , Hou David , Xiao Ting , Fischietti Mariafausta , Kang Seong Jae , Appin Christina L. , Horbinski Craig , Platanias Leonidas C. , Lopez-Rosas Aurora , Han Yu , Balyasnikova Irina V. , Lesniak Maciej S.
Published: April 2023

Supplementary figures
Supplementary Data from Targeting the YB-1/PD-L1 Axis to Enhance Chemotherapy and Antitumor Immunity
Authors: Tao Zhen , Ruan Hailong , Sun Lin , Kuang Dong , Song Yongchun , Wang Qi , Wang Tao , Hao Yi , Chen Ke
Published: April 2023

Supplementary figure legends and figure
Supplementary Table 4 from Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal Cancer
Authors: Lo Winifred , Parkhurst Maria , Robbins Paul F. , Tran Eric , Lu Yong-Chen , Jia Li , Gartner Jared J. , Pasetto Anna , Deniger Drew , Malekzadeh Parisa , Shelton Thomas E. , Prickett Todd , Ray Satyajit , Kivitz Scott , Paria Biman C. , Kriley Isaac , Schrump David S. , Rosenberg Steven A.
Published: April 2023

Supplementary Table 4
Supplementary Figures from TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
Authors: Holtzhausen Alisha , Harris William , Ubil Eric , Hunter Debra M. , Zhao Jichen , Zhang Yuewei , Zhang Dehui , Liu Qingyang , Wang Xiaodong , Graham Douglas K. , Frye Stephen V. , Earp H. Shelton
Published: April 2023

Supplementary Figures 1-6
Supplemental Figure Legends from TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
Authors: Holtzhausen Alisha , Harris William , Ubil Eric , Hunter Debra M. , Zhao Jichen , Zhang Yuewei , Zhang Dehui , Liu Qingyang , Wang Xiaodong , Graham Douglas K. , Frye Stephen V. , Earp H. Shelton
Published: April 2023

legends for sup figures 1-6
Supplemental Figure Legends from IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
Authors: Alizadeh Darya , Wong Robyn A. , Yang Xin , Wang Dongrui , Pecoraro Joseph R. , Kuo Cheng-Fu , Aguilar Brenda , Qi Yue , Ann David K. , Starr Renate , Urak Ryan , Wang Xiuli , Forman Stephen J. , Brown Christine E.
Published: April 2023

Legends for Supplemental Figures 1-9 and Supplemental Table 1
Table S2 from T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity
Authors: Sharma Preeti , Harris Daniel T. , Stone Jennifer D. , Kranz David M.
Published: April 2023

Supplementary Table S2: List of human peptides containing the central "GIG" motif required by T1, RD1, Mel5 and DMF5 TCRs.
Supplementary figure S1 and supplementary figure legend from Association of Probiotic Clostridium butyricum Therapy with Survival and Response to Immune Checkpoint Blockade in Patients with Lung Cancer
Authors: Tomita Yusuke , Ikeda Tokunori , Sakata Shinya , Saruwatari Koichi , Sato Ryo , Iyama Shinji , Jodai Takayuki , Akaike Kimitaka , Ishizuka Shiho , Saeki Sho , Sakagami Takuro
Published: April 2023

Association of antibiotic therapy within 60 days before the start of ICI therapy with survival in patients with NSCLC.
Supplementary Methods and Figure Legends from Hypoxia-Induced VISTA Promotes the Suppressive Function of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Authors: Deng Jie , Li Jiannan , Sarde Aurelien , Lines J. Louise , Lee Yu-Chi , Qian David C. , Pechenick Dov A. , Manivanh Richard , Le Mercier Isabelle , Lowrey Christopher H. , Varn Frederick S. , Cheng Chao , Leib David A. , Noelle Randolph J. , Mabaera Rodwell
Published: April 2023

Supplementary Methods and Figure Legends
Supplementary Data from Cancer Immunotherapy with T Cells Carrying Bispecific Receptors That Mimic Antibodies
Authors: Ahn Sarah , Li Jingjing , Sun Chuang , Gao Keliang , Hirabayashi Koichi , Li Hongxia , Savoldo Barbara , Liu Rihe , Dotti Gianpietro
Published: April 2023

Supplementary figures 1-6
Supplementary Fig. S1-S5 from TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer
Authors: Han Jiefei , Duan Jianchun , Bai Hua , Wang Yuqi , Wan Rui , Wang Xin , Chen Si , Tian Yanhua , Wang Di , Fei Kailun , Yao Zhuoran , Wang Shuhang , Lu Zhimin , Wang Zhijie , Wang Jie
Published: April 2023

Supplementary Figures 1-5
Table S1 from Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas
Authors: Bockmayr Michael , Klauschen Frederick , Maire Cecile L. , Rutkowski Stefan , Westphal Manfred , Lamszus Katrin , Schüller Ulrich , Mohme Malte
Published: April 2023

Summary of cases, clinical variables and expression of immune signatures.
Figure S3 from Virus-Like Particle–Drug Conjugates Induce Protective, Long-lasting Adaptive Antitumor Immunity in the Absence of Specifically Targeted Tumor Antigens
Authors: Kines Rhonda C. , Thompson Cynthia D. , Spring Sean , Li Zhenyu , de los Pinos Elisabet , Monks Stephen , Schiller John T.
Published: April 2023

AU-011 induced ROS activity, optimization and efficacy in other tumor models.
Figure S2 from Virus-Like Particle–Drug Conjugates Induce Protective, Long-lasting Adaptive Antitumor Immunity in the Absence of Specifically Targeted Tumor Antigens
Authors: Kines Rhonda C. , Thompson Cynthia D. , Spring Sean , Li Zhenyu , de los Pinos Elisabet , Monks Stephen , Schiller John T.
Published: April 2023

Detection of immunogenic cell death markers on TC-1 cells.
Supplementary Figures from Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses
Authors: Greaney Samantha K. , Algazi Alain P. , Tsai Katy K. , Takamura Kathryn T. , Chen Lawrence , Twitty Christopher G. , Zhang Li , Paciorek Alan , Pierce Robert H. , Le Mai H. , Daud Adil I. , Fong Lawrence
Published: April 2023

Supplementary Figures
Supplementary Data from Intratumoral Delivery of a PD-1–Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT Blockade
Authors: Lin Chaolong , Ren Wenfeng , Luo Yong , Li Shaopeng , Chang Yating , Li Lu , Xiong Dan , Huang Xiaoxuan , Xu Zilong , Yu Zeng , Wang Yingbin , Zhang Jun , Huang Chenghao , Xia Ningshao
Published: April 2023

Supplementary Figures and Legends
Supplementary Figures S1-S9 from Identification of the Cryptic HLA-I Immunopeptidome
Authors: Erhard Florian , Dölken Lars , Schilling Bastian , Schlosser Andreas
Published: April 2023

Fig. S1. Total peak intensities of cryptic and conventional peptides Fig. S2. Validation of cryptic peptides by mass spectrometry of synthetic peptides Fig. S3. Distribution of peptide categories in all data sets Fig. S4. Predicted binding affinities of peptide categories for all data sets Fig. S5. Extended analysis of PCPS peptides Fig. S6. Extended analysis of peptides with single amino acid substitutions Fig. S7. A reported neoantigen is in fact a cryptic peptide Fig. S8. An intronic peptide Fig. S9. Amino acid bias and HLA-I allele preference of cryptic peptides
Table S1 from Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy
Authors: Liang Jiyong , Wang Lulu , Wang Chao , Shen Jianfeng , Su Bojin , Marisetty Anantha L. , Fang Dexing , Kassab Cynthia , Jeong Kang Jin , Zhao Wei , Lu Yiling , Jain Abhinav K. , Zhou Zhicheng , Liang Han , Sun Shao-Cong , Lu Changming , Xu Zhi-Xiang , Yu Qinghua , Shao Shan , Chen XiaoHua , Gao Meng , Claret Francois X. , Ding Zhiyong , Chen Jian , Chen Pingsheng , Barton Michelle C. , Peng Guang , Mills Gordon B. , Heimberger Amy B.
Published: April 2023

Supplemental Table S1
Figure S5 from Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy
Authors: Liang Jiyong , Wang Lulu , Wang Chao , Shen Jianfeng , Su Bojin , Marisetty Anantha L. , Fang Dexing , Kassab Cynthia , Jeong Kang Jin , Zhao Wei , Lu Yiling , Jain Abhinav K. , Zhou Zhicheng , Liang Han , Sun Shao-Cong , Lu Changming , Xu Zhi-Xiang , Yu Qinghua , Shao Shan , Chen XiaoHua , Gao Meng , Claret Francois X. , Ding Zhiyong , Chen Jian , Chen Pingsheng , Barton Michelle C. , Peng Guang , Mills Gordon B. , Heimberger Amy B.
Published: April 2023

Supplemental Figure S5
Figure S4 from Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy
Authors: Liang Jiyong , Wang Lulu , Wang Chao , Shen Jianfeng , Su Bojin , Marisetty Anantha L. , Fang Dexing , Kassab Cynthia , Jeong Kang Jin , Zhao Wei , Lu Yiling , Jain Abhinav K. , Zhou Zhicheng , Liang Han , Sun Shao-Cong , Lu Changming , Xu Zhi-Xiang , Yu Qinghua , Shao Shan , Chen XiaoHua , Gao Meng , Claret Francois X. , Ding Zhiyong , Chen Jian , Chen Pingsheng , Barton Michelle C. , Peng Guang , Mills Gordon B. , Heimberger Amy B.
Published: April 2023

Supplemental Figure S4
Supplementary Table 1 from Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
Authors: Xin Gang , Chen Yao , Topchyan Paytsar , Kasmani Moujtaba Y. , Burns Robert , Volberding Peter J. , Wu Xiaopeng , Cohn Alexandra , Chen Yiliang , Lin Chien-Wei , Ho Ping-Chih , Silverstein Roy , Dwinell Michael B. , Cui Weiguo
Published: April 2023

Supplementary Table 1
Supplementary Data from CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study
Authors: Wei Guoqing , Zhang Yanlei , Zhao Houli , Wang Yiyun , Liu Yandan , Liang Bin , Wang Xiujian , Xu Huijun , Cui Jiazhen , Wu Wenjun , Zhao Kui , Nagler Arnon , Chang Alex H. , Hu Yongxian , Huang He
Published: April 2023

Supplementary materials
Supplementary Figures from Chronic Adrenergic Stress Contributes to Metabolic Dysfunction and an Exhausted Phenotype in T Cells in the Tumor Microenvironment
Authors: Qiao Guanxi , Chen Minhui , Mohammadpour Hemn , MacDonald Cameron R. , Bucsek Mark J. , Hylander Bonnie L. , Barbi Joseph J. , Repasky Elizabeth A.
Published: April 2023

Supplementary Figures 1-7
Supplementary Movie 2 from An Antibody Targeting ICOS Increases Intratumoral Cytotoxic to Regulatory T-cell Ratio and Induces Tumor Regression
Authors: Sainson Richard C.A. , Thotakura Anil K. , Kosmac Miha , Borhis Gwenoline , Parveen Nahida , Kimber Rachael , Carvalho Joana , Henderson Simon J. , Pryke Kerstin L. , Okell Tracey , O'Leary Siobhan , Ball Stuart , Van Krinks Cassie , Gamand Lauriane , Taggart Emma , Pring Eleanor J. , Ali Hanif , Craig Hannah , Wong Vivian W.Y. , Liang Qi , Rowlands Robert J. , Lecointre Morgane , Campbell Jamie , Kirby Ian , Melvin David , Germaschewski Volker , Oelmann Elisabeth , Quaratino Sonia , McCourt Matthew
Published: April 2023

Isotype control
Supplementary Figures 1-11 from IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D
Authors: Kiss Máté , Vande Walle Lieselotte , Saavedra Pedro H.V. , Lebegge Els , Van Damme Helena , Murgaski Aleksandar , Qian Junbin , Ehling Manuel , Pretto Samantha , Bolli Evangelia , Keirsse Jiri , Bardet Pauline M.R. , Arnouk Sana M. , Elkrim Yvon , Schmoetten Maryse , Brughmans Jan , Debraekeleer Ayla , Fossoul Amelie , Boon Louis , Raes Geert , van Loo Geert , Lambrechts Diether , Mazzone Massimiliano , Beschin Alain , Wullaert Andy , Lamkanfi Mohamed , Van Ginderachter Jo A. , Laoui Damya
Published: April 2023

Supplementary Figures 1-11
Supplementary Table 2 from Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T
Authors: Zhang Li , Kandadi Harini , Yang Hai , Cham Jason , He Tao , Oh David Y. , Sheikh Nadeem A. , Fong Lawrence
Published: April 2023

Supplementary Table 2. The public clones shared between treated patients at baseline and naïve patients at post-baseline time points. The table is separated by the 5 public clones, for which, each was shared by two treated patients and two naïve patients. For each clone, the corresponding amino acid sequence, gene information, as well as their abundance at each timepoint for each shared patient were listed. NA = the corresponding blood sample was not available at that time point. 0 = the corresponding clonotype was not detected in the available blood sample.
Table S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development
Authors: Gui Xun , Deng Mi , Song Hao , Chen Yuanzhi , Xie Jingjing , Li Zunling , He Licai , Huang Fangfang , Xu Yixiang , Anami Yasuaki , Yu Hai , Yu Chenyi , Li Leike , Yuan Zihao , Xu Xiaoying , Wang Qihui , Chai Yan , Huang Tao , Shi Yi , Tsuchikama Kyoji , Liao X. Charlene , Xia Ningshao , Gao George F. , Zhang Ningyan , Zhang Cheng Cheng , An Zhiqiang
Published: April 2023

Data collection and refinement statistics.
Figure S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development
Authors: Gui Xun , Deng Mi , Song Hao , Chen Yuanzhi , Xie Jingjing , Li Zunling , He Licai , Huang Fangfang , Xu Yixiang , Anami Yasuaki , Yu Hai , Yu Chenyi , Li Leike , Yuan Zihao , Xu Xiaoying , Wang Qihui , Chai Yan , Huang Tao , Shi Yi , Tsuchikama Kyoji , Liao X. Charlene , Xia Ningshao , Gao George F. , Zhang Ningyan , Zhang Cheng Cheng , An Zhiqiang
Published: April 2023

Screening of anti-LILRB4 rabbit mAbs.
Supplementary Figures from The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma
Authors: Wang Xiuli , Huynh Christian , Urak Ryan , Weng Lihong , Walter Miriam , Lim Laura , Vyas Vibhuti , Chang Wen-Chung , Aguilar Brenda , Brito Alfonso , Sarkissian Aniee , Bandara N. Achini , Yang Lu , Wang Jinhui , Wu Xiwei , Zhang Jianying , Priceman Saul J. , Qin Hong , Kwak Larry W. , Budde Lihua E. , Thomas Sandra H. , Clark Mary C. , Popplewell Leslie , Siddiqi Tanya , Brown Christine E. , Forman Stephen J.
Published: April 2023

Supplementary Figures and Legends
Supplementary Table 1 from Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype
Authors: Jaiswal Ashvin R. , Liu Arthur J. , Pudakalakatti Shivanand , Dutta Prasanta , Jayaprakash Priyamvada , Bartkowiak Todd , Ager Casey R. , Wang Zhi-Qiang , Reuben Alexandre , Cooper Zachary A. , Ivan Cristina , Ju Zhenlin , Nwajei Felix , Wang Jing , Davies Michael A. , Davis R. Eric , Wargo Jennifer A. , Bhattacharya Pratip K. , Hong David S. , Curran Michael A.
Published: April 2023

Patient Demographics and Responses
Supplementary Tables 1-4 from DGKA Mediates Resistance to PD-1 Blockade
Authors: Fu Lingyi , Li Sen , Xiao WeiWei , Yu Kuai , Li Shuo , Yuan Sujing , Shen Jianfei , Dong Xingjun , Fang Ziqian , Zhang Jianeng , Chen Siyu , Li Wende , You Hua , Xia Xiaojun , Kang Tiebang , Tan Jing , Chen Gong , Yang An-Kui , Gao YuanHong , Zhou Penghui
Published: April 2023

Supplementary Tables 1-4
Supplementary Table S1 from DGKA Mediates Resistance to PD-1 Blockade
Authors: Fu Lingyi , Li Sen , Xiao WeiWei , Yu Kuai , Li Shuo , Yuan Sujing , Shen Jianfei , Dong Xingjun , Fang Ziqian , Zhang Jianeng , Chen Siyu , Li Wende , You Hua , Xia Xiaojun , Kang Tiebang , Tan Jing , Chen Gong , Yang An-Kui , Gao YuanHong , Zhou Penghui
Published: April 2023

Supplementary Table S1
Supplementary Figure 5 from DGKA Mediates Resistance to PD-1 Blockade
Authors: Fu Lingyi , Li Sen , Xiao WeiWei , Yu Kuai , Li Shuo , Yuan Sujing , Shen Jianfei , Dong Xingjun , Fang Ziqian , Zhang Jianeng , Chen Siyu , Li Wende , You Hua , Xia Xiaojun , Kang Tiebang , Tan Jing , Chen Gong , Yang An-Kui , Gao YuanHong , Zhou Penghui
Published: April 2023

Supplementary Figure 5
Supplementary Legends from Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition
Authors: Xia Lin , Zheng Zaozao , Liu Jun-yi , Chen Yu-jie , Ding Jiancheng , Hu Guo-sheng , Hu Ya-hong , Liu Suling , Luo Wen-xin , Xia Ning-shao , Liu Wen
Published: April 2023

Supplementary Legends for Figures and Tables
Supplementary Figures from Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition
Authors: Xia Lin , Zheng Zaozao , Liu Jun-yi , Chen Yu-jie , Ding Jiancheng , Hu Guo-sheng , Hu Ya-hong , Liu Suling , Luo Wen-xin , Xia Ning-shao , Liu Wen
Published: April 2023

All Supplementary Figures (1-9)
Supplementary Figure 3 from The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth
Authors: Chen Siqi , Akdemir Imran , Fan Jie , Linden Joel , Zhang Bin , Cekic Caglar
Published: April 2023

Supplementary Figure 3
Supplementary Figure 2 from The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth
Authors: Chen Siqi , Akdemir Imran , Fan Jie , Linden Joel , Zhang Bin , Cekic Caglar
Published: April 2023

Supplementary Figure 2
Supplementary Data from Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1–Mediated Immune Evasion in Prostate Cancer
Authors: Ruan Hailong , Bao Lin , Tao Zhen , Chen Ke
Published: April 2023

Supplementary data
Supplemental Figure Video S2 from Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity
Authors: Sakemura Reona , Bansal Aditya , Siegler Elizabeth L. , Hefazi Mehrdad , Yang Nan , Khadka Roman H. , Newsom Alysha N. , Hansen Michael J. , Cox Michelle J. , Manriquez Roman Claudia , Schick Kendall J. , Can Ismail , Tapper Erin E. , Nevala Wendy K. , Adada Mohamad M. , Bezerra Evandro D. , Kankeu Fonkoua Lionel Aurelien , Horvei Paulina , Ruff Michael W. , Parikh Sameer A. , Pandey Mukesh K. , DeGrado Timothy R. , Suksanpaisan Lukkana , Kay Neil E. , Peng Kah-Whye , Russell Stephen J. , Kenderian Saad S.
Published: April 2023

Supplemental Figure Video
Supplemental Figure Video S1 from Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity
Authors: Sakemura Reona , Bansal Aditya , Siegler Elizabeth L. , Hefazi Mehrdad , Yang Nan , Khadka Roman H. , Newsom Alysha N. , Hansen Michael J. , Cox Michelle J. , Manriquez Roman Claudia , Schick Kendall J. , Can Ismail , Tapper Erin E. , Nevala Wendy K. , Adada Mohamad M. , Bezerra Evandro D. , Kankeu Fonkoua Lionel Aurelien , Horvei Paulina , Ruff Michael W. , Parikh Sameer A. , Pandey Mukesh K. , DeGrado Timothy R. , Suksanpaisan Lukkana , Kay Neil E. , Peng Kah-Whye , Russell Stephen J. , Kenderian Saad S.
Published: April 2023

Supplemental Figure Video
Supplemental Table Legends from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers
Authors: Colbert Lauren E. , El Molly B. , Lynn Erica J. , Bronk Julianna , Karpinets Tatiana V. , Wu Xiaogang , Chapman Bhavana V. , Sims Travis T. , Lin Daniel , Kouzy Ramez , Sammouri Julie , Biegert Greyson , Delgado Medrano Andrea Y. , Olvera Adilene , Sastry K. Jagannadha , Eifel Patricia J. , Jhingran Anuja , Lin Lilie , Ramondetta Lois M. , Futreal Andrew P. , Jazaeri Amir A. , Schmeler Kathleen M. , Yue Jingyan , Mitra Aparna , Yoshida-Court Kyoko , Wargo Jennifer A. , Solley Travis N. , Hegde Venkatesh , Nookala Sita S. , Yanamandra Ananta V. , Dorta-Estremera Stephanie , Mathew Geena , Kavukuntla Rohit , Papso Cassidy , Ahmed-Kaddar Mustapha , Kim Minsoo , Zhang Jianhua , Reuben Alexandre , Holliday Emma B. , Minsky Bruce D. , Koong Albert C. , Koay Eugene J. , Das Prajnan , Taniguchi Cullen M. , Klopp Ann
Published: April 2023

Supplemental Table Legends
Supplemental Table Legends
Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
Authors: Fedoriw Andrew , Shi Leilei , O'Brien Shane , Smitheman Kimberly N. , Wang Yunfei , Hou Jiakai , Sherk Christian , Rajapurkar Satyajit , Laraio Jenny , Williams Leila J. , Xu Chunyu , Han Guangchun , Feng Qin , Bedford Mark T. , Wang Linghua , Barbash Olena , Kruger Ryan G. , Hwu Patrick , Mohammad Helai P. , Peng Weiyi
Published: April 2023

Supplementary Table from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
Authors: Fedoriw Andrew , Shi Leilei , O'Brien Shane , Smitheman Kimberly N. , Wang Yunfei , Hou Jiakai , Sherk Christian , Rajapurkar Satyajit , Laraio Jenny , Williams Leila J. , Xu Chunyu , Han Guangchun , Feng Qin , Bedford Mark T. , Wang Linghua , Barbash Olena , Kruger Ryan G. , Hwu Patrick , Mohammad Helai P. , Peng Weiyi
Published: April 2023

Supplementary Figure from Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses
Supplementary Tables and Figures from ST8Sia6 Promotes Tumor Growth in Mice by Inhibiting Immune Responses
Authors: Friedman David J. , Crotts Sydney B. , Shapiro Michael J. , Rajcula Matthew , McCue Shaylene , Liu Xin , Khazaie Khashayarsha , Dong Haidong , Shapiro Virginia Smith
Published: April 2023

Supplementary Tables S1-S2 and Supplementary Figures S1-S6
Supplementary Figure from Loss of LRRC33-Dependent TGFβ1 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy
Authors: Jiang Aiping , Qin Yan , Springer Timothy A.
Published: April 2023

Supplementary Figure from Loss of LRRC33-Dependent TGFβ1 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy
Supplementary Figures from NKG7 Is Required for Optimal Antitumor T-cell Immunity
Authors: Li Xian-Yang , Corvino Dillon , Nowlan Bianca , Aguilera Amelia Roman , Ng Susanna S. , Braun Matthias , Cillo Anthony R. , Bald Tobias , Smyth Mark J. , Engwerda Christian R.
Published: April 2023

Supplementary Figures
Supplementary Figures
Supplementary Data from Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
Authors: Samson Adel , West Emma J. , Carmichael Jonathan , Scott Karen J. , Turnbull Samantha , Kuszlewicz Bethany , Dave Rajiv V. , Peckham-Cooper Adam , Tidswell Emma , Kingston Jennifer , Johnpulle Michelle , da Silva Barbara , Jennings Victoria A. , Bendjama Kaidre , Stojkowitz Nicolas , Lusky Monika , Prasad K.R. , Toogood Giles J. , Auer Rebecca , Bell John , Twelves Chris J. , Harrington Kevin J. , Vile Richard G. , Pandha Hardev , Errington-Mais Fiona , Ralph Christy , Newton Darren J. , Anthoney Alan , Melcher Alan A. , Collinson Fiona
Published: April 2023

Supplementary Data from Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients
Table S1 from Integrin β7 Inhibits Colorectal Cancer Pathogenesis via Maintaining Antitumor Immunity
Authors: Zhang Youhua , Xie Ruting , Zhang Hailong , Zheng Yajuan , Lin Changdong , Yang Lei , Huang Mengwen , Li Man , Song Feifei , Lu Ling , Yang Muqing , Liu Ying , Wei Qing , Li Jiyu , Chen Jianfeng
Published: April 2023

Supplementary Table 1
Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
Authors: Chen Yu , Cai Qiaomei , Pan Chaohu , Liu Wancheng , Li Lili , Liu Junxiao , Gao Meiling , Li Xiaorong , Wang Liguo , Rao Yu , Yang Heng , Cheng Genhong
Published: April 2023

Supplementary Table from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
Supplementary Figure from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
Authors: Chen Yu , Cai Qiaomei , Pan Chaohu , Liu Wancheng , Li Lili , Liu Junxiao , Gao Meiling , Li Xiaorong , Wang Liguo , Rao Yu , Yang Heng , Cheng Genhong
Published: April 2023

Supplementary Figure from CDK2 Inhibition Enhances Antitumor Immunity by Increasing IFN Response to Endogenous Retroviruses
Supplementary Data from Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment
Authors: Sidiropoulos Dimitrios N. , Rafie Christine I. , Jang Julie K. , Castanon Sofi , Baugh Aaron G. , Gonzalez Edgar , Christmas Brian J. , Narumi Valerie H. , Davis-Marcisak Emily F. , Sharma Gaurav , Bigelow Emma , Vaghasia Ajay , Gupta Anuj , Skaist Alyza , Considine Michael , Wheelan Sarah J. , Ganesan Sathish Kumar , Yu Min , Yegnasubramanian Srinivasan , Stearns Vered , Connolly Roisin M. , Gaykalova Daria A. , Kagohara Luciane T. , Jaffee Elizabeth M. , Fertig Elana J. , Roussos Torres Evanthia T.
Published: April 2023

Supplementary Data from Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment
Supplementary Figure from Overproduction of IFNγ by Cbl-b–Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity
Authors: Han SeongJun , Liu Zhe Qi , Chung Douglas C. , Paul Michael St. , Garcia-Batres Carlos R. , Sayad Azin , Elford Alisha R. , Gold Matthew J. , Grimshaw Natasha , Ohashi Pamela S.
Published: April 2023

Supplementary Figure from Overproduction of IFNγ by Cbl-b–Deficient CD8+ T Cells Provides Resistance against Regulatory T Cells and Induces Potent Antitumor Immunity
Supplementary Table S1 from γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer
Authors: Ji Niannian , Mukherjee Neelam , Shu Zhen-Ju , Reyes Ryan M. , Meeks Joshua J. , McConkey David J. , Gelfond Jonathan A. , Curiel Tyler J. , Svatek Robert S.
Published: April 2023

Reagent information for flow cytometry and ELISPOT assay.
Table S2 from The SETDB1–TRIM28 Complex Suppresses Antitumor Immunity
Authors: Lin Jianhuang , Guo Dajiang , Liu Heng , Zhou Wei , Wang Chen , Müller Iris , Kossenkov Andrew V. , Drapkin Ronny , Bitler Benjamin G. , Helin Kristian , Zhang Rugang
Published: April 2023

Table S2 shows that original data on TMA staining.
Movie S8 from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
Authors: Kantari-Mimoun Chahrazade , Barrin Sarah , Vimeux Lene , Haghiri Sandrine , Gervais Claire , Joaquina Sandy , Mittelstaet Joerg , Mockel-Tenbrinck Nadine , Kinkhabwala Ali , Damotte Diane , Lupo Audrey , Sibony Mathilde , Alifano Marco , Dondi Elisabetta , Bercovici Nadège , Trautmann Alain , Kaiser Andrew D. , Donnadieu Emmanuel
Published: April 2023

Distribution and migration and EGFR CAR T cells in a vibratome section of a human renal tumor
Movie S5 from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
Authors: Kantari-Mimoun Chahrazade , Barrin Sarah , Vimeux Lene , Haghiri Sandrine , Gervais Claire , Joaquina Sandy , Mittelstaet Joerg , Mockel-Tenbrinck Nadine , Kinkhabwala Ali , Damotte Diane , Lupo Audrey , Sibony Mathilde , Alifano Marco , Dondi Elisabetta , Bercovici Nadège , Trautmann Alain , Kaiser Andrew D. , Donnadieu Emmanuel
Published: April 2023

EGFR CAR T cells accumulate and stop at the periphery of BxPC3 tumor islets
Movie S3 from CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1
Authors: Kantari-Mimoun Chahrazade , Barrin Sarah , Vimeux Lene , Haghiri Sandrine , Gervais Claire , Joaquina Sandy , Mittelstaet Joerg , Mockel-Tenbrinck Nadine , Kinkhabwala Ali , Damotte Diane , Lupo Audrey , Sibony Mathilde , Alifano Marco , Dondi Elisabetta , Bercovici Nadège , Trautmann Alain , Kaiser Andrew D. , Donnadieu Emmanuel
Published: April 2023

Ca2+ responses of Fura-2-loaded EGFR CAR T cells during their interaction with BxPC3 tumor cells
Supplementary Tables from CD137 Costimulation Counteracts TGFβ Inhibition of NK-cell Antitumor Function
Authors: Cabo Mariona , Santana-Hernández Sara , Costa-Garcia Marcel , Rea Anna , Lozano-Rodríguez Roberto , Ataya Michelle , Balaguer Francesc , Juan Manel , Ochoa Maria C. , Menéndez Silvia , Comerma Laura , Rovira Ana , Berraondo Pedro , Albanell Joan , Melero Ignacio , López-Botet Miguel , Muntasell Aura
Published: April 2023

Supplementary Tables 1-2
Video 4 from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
Authors: Wellinger Lisa C. , Hogg Simon J. , Newman Dane M. , Friess Thomas , Geiss Daniela , Michie Jessica , Ramsbottom Kelly M. , Bacac Marina , Fauti Tanja , Marbach Daniel , Jarassier Laura , Thienger Phillip , Paehler Axel , Cluse Leonie A. , Kearney Conor J. , Vervoort Stephin J. , Trapani Joseph A. , Oliaro Jane , Shortt Jake , Ruefli-Brasse Astrid , Rohle Daniel , Johnstone Ricky W.
Published: April 2023

Supp Video 4
Supplementary Table 1 from β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor Rejection
Authors: Guenther Carla , Faisal Imrul , Fusciello Manlio , Sokolova Maria , Harjunpää Heidi , Ilander Mette , Tallberg Robert , Vartiainen Maria Kristina , Alon Ronen , Gonzalez-Granado Jose-Maria , Cerullo Vincenzo , Fagerholm Susanna Carola
Published: April 2023

Supplementary Table 1
Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
Authors: Pourmaleki Maryam , Jones Caitlin J. , Ariyan Charlotte E. , Zeng Zheng , Pirun Mono , Navarrete Daniel A. , Li Yanyun , Zhang Mianlei , Nandakumar Subhiksha , Campos Carl , Nadeem Saad , Klimstra David S. , Temple-Oberle Claire F. , Brenn Thomas , Lipson Evan J. , Schenk Kara M. , Stein Julie E. , Taube Janis M. , White Michael G. , Traweek Raymond , Wargo Jennifer A. , Kirkwood John M. , Gasmi Billel , Goff Stephanie L. , Corwin Alex D. , McDonough Elizabeth , Ginty Fiona , Callahan Margaret K. , Schietinger Andrea , Socci Nicholas D. , Mellinghoff Ingo K. , Hollmann Travis J.
Published: April 2023

Supplementary Data from Tumor MHC Class I Expression Associates with Intralesional IL2 Response in Melanoma
Supplementary Figure from Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid Tumors
Authors: Brog Rachel A. , Ferry Shannon L. , Schiebout Courtney T. , Messier Cameron M. , Cook W. James , Abdullah Leena , Zou Jia , Kumar Prathna , Sentman Charles L. , Frost H. Robert , Huang Yina H.
Published: April 2023

Supplementary Figure from Superkine IL-2 and IL-33 Armored CAR T Cells Reshape the Tumor Microenvironment and Reduce Growth of Multiple Solid Tumors
Table S7 from Cancer Cell Resistance to IFNγ Can Occur via Enhanced Double-Strand Break Repair Pathway Activity
Authors: Han Tong , Wang Xujun , Shi Sailing , Zhang Wubing , Wang Jue , Wu Qiu , Li Ziyi , Fu Jingxin , Zheng Rongbin , Zhang Jiamin , Tang Qin , Zhang Peng , Wang Chenfei
Published: April 2023

Cox regression model of IFNG expression on patients’ survival in TCGA and Available expression data of ICB treatment.
Table S6 from Cancer Cell Resistance to IFNγ Can Occur via Enhanced Double-Strand Break Repair Pathway Activity
Authors: Han Tong , Wang Xujun , Shi Sailing , Zhang Wubing , Wang Jue , Wu Qiu , Li Ziyi , Fu Jingxin , Zheng Rongbin , Zhang Jiamin , Tang Qin , Zhang Peng , Wang Chenfei
Published: April 2023

Expression of DSB repair genes especially resistant or non-resistant DSB repair genes in TCGA datasets with SSB repair genes mutation and deletion.
Supplementary Data from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors
Authors: Slaats Jeroen , Wagena Esther , Smits Daan , Berends Annemarie A. , Peters Ella , Bakker Gert-Jan , van Erp Merijn , Weigelin Bettina , Adema Gosse J. , Friedl Peter
Published: April 2023

Supplementary Data from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors
Supplementary Table S4 from High-Resolution Analysis of Mononuclear Phagocytes Reveals GPNMB as a Prognostic Marker in Human Colorectal Liver Metastasis
Authors: Cortese Nina , Carriero Roberta , Barbagallo Marialuisa , Putignano Anna Rita , Costa Guido , Giavazzi Fabio , Grizzi Fabio , Pasqualini Fabio , Peano Clelia , Basso Gianluca , Marchini Sergio , Colombo Federico Simone , Soldani Cristiana , Franceschini Barbara , Di Tommaso Luca , Terracciano Luigi , Donadon Matteo , Torzilli Guido , Kunderfranco Paolo , Mantovani Alberto , Marchesi Federica
Published: April 2023

Supplementary Table S4
Supplementary Figures and Table from Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells
Authors: Hoefsmit Esmée P. , van Royen Paula T. , Rao Disha , Stunnenberg Johanna A. , Dimitriadis P. , Lieftink Cor , Morris Ben , Rozeman Elisa A. , Reijers Irene L.M. , Lacroix Ruben , Shehwana Huma , Ligtenberg Maarten A. , Beijersbergen Roderick L. , Peeper Daniel S. , Blank Christian U.
Published: April 2023

Supplementary Data file, Figure S1-S9, Table S1
Supplementary Data from IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model
Authors: Lutz Veronika , Hellmund Veronique M. , Picard Felix S.R. , Raifer Hartmann , Ruckenbrod Teresa , Klein Matthias , Bopp Tobias , Savai Rajkumar , Duewell Peter , Keber Corinna U. , Weigert Andreas , Chung Ho-Ryun , Buchholz Malte , Menke André , Gress Thomas M. , Huber Magdalena , Bauer Christian
Published: April 2023

Supplementary Table S1-3 and Figures S1-6